The Enterprise Value as of December 2025 (TTM) for BrightPath Biotherapeutics Co., Ltd. (4594.T) is 3.72B

According to BrightPath Biotherapeutics Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.72B. This represents a change of 16.36% compared to the average of 3.20B of the last 4 quarters.

BrightPath Biotherapeutics Co., Ltd. (4594.T) Historical Enterprise Value (quarterly & annually)

How has 4594.T Enterprise Value performed in the past?

The mean historical Enterprise Value of BrightPath Biotherapeutics Co., Ltd. over the last ten years is 10.02B. The current 3.72B Enterprise Value has changed 3.62% with respect to the historical average. Over the past ten years (40 quarters), 4594.T's Enterprise Value was at its highest in in the March 2018 quarter at 26.52B. The Enterprise Value was at its lowest in in the September 2022 quarter at 2.08B.

BrightPath Biotherapeutics Co., Ltd. (4594.T) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BrightPath Biotherapeutics Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BrightPath Biotherapeutics Co., Ltd. (4594.T) Average Enterprise Value

How has 4594.T Enterprise Value performed in the past?

The current Enterprise Value of BrightPath Biotherapeutics Co., Ltd. (4594.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BrightPath Biotherapeutics Co., Ltd. (4594.T) Enterprise Value vs. Peers

How is 4594.T’s Enterprise Value compared to its peers?

BrightPath Biotherapeutics Co., Ltd.’s Enterprise Value is less than ADR120S, Inc. (7.07B), less than OncoTherapy Science, Inc. (5.92B), less than K Pharma,Inc. (5.59B), greater than Noile-Immune Biotech Inc. (2.66B), greater than TMS Co., Ltd. (2.91B), greater than PRISM BioLab Co.,LTD (3.21B), greater than Linical Co., Ltd. (3.51B), less than Chiome Bioscience Inc. (6.34B), less than Kohjin Bio Co., Ltd. (6.85B), less than MedRx Co., Ltd (4.86B),

Build a custom stock screener for BrightPath Biotherapeutics Co., Ltd. (4594.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BrightPath Biotherapeutics Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BrightPath Biotherapeutics Co., Ltd. (4594.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BrightPath Biotherapeutics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.